Exhicon Events Media Solutions Fund Raise of ₹107.4 Cr

Exhicon Events Media Solutions Management Change

Exhicon appointed Nilesh Kumar Dubey as CEO–Venue Development, effective October 26, 2026. He will lead Mohali Exhibition Centre Phase 1 to commercial launch by May 2027.

Exhicon Events Media Solutions Other Announcement

The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.

Exhicon Events Media Solutions Acquisition

Exhicon subsidiary UHPL acquired a Bell 206 L4 helicopter from Dhillon Aviation. The asset expands UHPL's charter fleet, subject to DGCA approvals.

Exhicon Events Media Solutions Other Announcement

Exhicon Events Media Solutions Ltd has re-appointed Bilimoria Mehta & Co. as its Statutory Auditor for a term of 60 months.

Exhicon Events Media Solutions Annual General Meeting

Exhicon Events Media Solutions held its 16th Annual General Meeting on September 24, 2026. Members approved the financial statements, Director re-appointment, and Statutory Auditor re-appointment.

Exhicon Events Media Solutions Merger & Restructuring

Exhicon Events sold 35% of subsidiary EMCCPL to India Exposition Mart in a JV for the Mohali Convention Centre, retaining 65% control.

Rite Zone Chemcon India Fund Raise of ₹6.58 Cr

Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.

Value

₹6.58 Cr

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value

₹72.00 Cr

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value

₹68.20 Cr

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value

₹16.99 Cr

Execution

Rights issue opens 23 November 2026 and closes 30 November 2026

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.

GAIL (India) Fund Raise

GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.